Ashbaugh, A. R., Cohen, J. N., & Dobson, K. S. (2021). Training in cognitive behavioural therapy (CBT): National training guidelines from the Canadian Association of Cognitive and Behavioural Therapies.
Canadian Psychology / Psychologie canadienne, 62(3), 239–251.
https://doi.org/10.1037/cap0000224
Bennebroek Evertsz’, F., Bockting, C. L., Braamse, A., van Dissel, M. N., Duijvestein, M., Kager, L. M., ... & Knoop, H. (2024). Implementation of ‘IBD-specific cognitive behavioural therapy’for patients with inflammatory bowel diseases with poor mental quality of life, anxiety and depression.
Journal of Clinical Psychology in Medical Settings,
31(2), 258-278.
https://doi.org/10.1007/s10880-023-09996-8
Donnet, A. S., Hasan, S. S., & Whorwell, P. J. (2022). Hypnotherapy for irritable bowel syndrome: patient expectations and perceptions.
Therapeutic Advances in Gastroenterology,
15(1), 1-10.
https://doi.org/10.1177/17562848221074208
Gonsalkorale, W. M., Miller, V., Afzal, A., & Whorwell, P. J. (2003). Long term benefits of hypnotherapy for irritable bowel syndrome.
Gut,
52(11), 1623-1629.
https://doi.org/10.1136/gut.52.11.1623
Gonzalez Trotter, D., Donahue, S., Wynne, C., Ali, S., Parasoglou, P., Boyapati, A., ... & Herman, G. A. (2025). GDF8 and activin A are the key negative regulators of muscle mass in postmenopausal females: a randomized phase I trial.
Nature Communications,
16(1), 1-14.
https://doi.org/10.1038/s41467-025-59380-3
Goodoory, V. C., Guthrie, E. A., Ng, C. E., Black, C. J., & Ford, A. C. (2023). Factors associated with lower disease‐specific and generic health‐related quality of life in Rome IV irritable bowel syndrome.
Alimentary Pharmacology & Therapeutics,
57(3), 323-334.
https://doi.org/10.1111/apt.17356
Haghayegh, S., Kalantari, M., Solati Dehkordi, S., Molavi, H., & Adibi, P. (2008). Preliminary study of the psychometric properties of the Persian version of the Quality of Life Questionnaire in Motile Bowel.
Journal of Govaresh, 13(2), 105-99.
https://sid.ir/paper/86089/fa [In Persian]
Hamid, N., Siavoshy, V., Fouladvand, H., & Ahmadi Farsani, M. (2022). The Efficacy of Cognitive-Behavioral Stress Management Training with Positive Imagination of Recovery on Quality of Life and General Health of Patients with Irritable Bowel Syndrome.
Journal of Modern Psychological Researches,
17(67), 107-115.
https://doi.org/10.22034/jmpr.2022.15317 [In Persian]
Hasan, S. S., Ballou, S., Keefer, L., & Vasant, D. H. (2023). Improving access to gut‐directed hypnotherapy for irritable bowel syndrome in the digital therapeutics' era: Are mobile applications a “smart” solution?.
Neurogastroenterology & Motility,
35(4), 1-10.
https://doi.org/10.1111/nmo.14554
Hoekman, D. R., Vlieger, A. M., Stokkers, P. C., Mahhmod, N., Rietdijk, S., de Boer, N. K., ... & Benninga, M. A. (2021). Hypnotherapy for irritable bowel syndrome-type symptoms in patients with quiescent inflammatory bowel disease: a randomized, controlled trial.
Journal of Crohn's and Colitis,
15(7), 1106-1113.
https://doi.org/10.1093/ecco-jcc/jjaa241
Hofmann, S. G., Asnaani, A., Vonk, I. J., Sawyer, A. T., & Fang, A. (2012). The efficacy of cognitive behavioral therapy: A review of meta-analyses.
Cognitive therapy and research,
36, 427-440.
https://doi.org/10.1007/s10608-012-9476-1
Khalil, J., Sun, Y., Kaelber, D., Lembo, A. J., & Song, G. (2024). S793 Hormone Replacement Therapy is Associated With Increased Risk of Developing Irritable Bowel Syndrome in Post-Menopausal Women.
Official journal of the American College of Gastroenterology| ACG,
119(10), 1-15.
https://doi.org/10.14309/01.ajg.0001032540.54524.37
Krouwel, M., Jolly, K., & Greenfield, S. (2017). What the public think about hypnosis and hypnotherapy: A narrative review of literature covering opinions and attitudes of the general public 1996–2016.
Complementary therapies in medicine,
32(1), 75-84.
https://doi.org/10.1016/j.ctim.2017.04.002
Krouwel, M., Jolly, K., & Greenfield, S. (2019). How do people with refractory irritable bowel syndrome perceive hypnotherapy?: Qualitative study.
Complementary Therapies in Medicine,
45 (1), 65-70.
https://doi.org/10.1016/j.ctim.2019.05.020
Lackner, J.M., & Jaccard, J. (2021). Specific and common mediators of gastrointestinal symptom improvement in patients undergoing education/support vs. cognitive behavioral therapy for irritable bowel syndrome.
J Consult Clin Psychol, 89(5), 435-453.
https://doi.org/10.1037/ccp0000648.
Lenhart, A., Naliboff, B., Shih, W., Gupta, A., Tillisch, K., Liu, C., ... & Chang, L. (2020). Postmenopausal women with irritable bowel syndrome (IBS) have more severe symptoms than premenopausal women with IBS.
Neurogastroenterology & Motility,
32(10), 1-10.
https://doi.org/10.1111/nmo.13913
Liu, Q., Zhu, Y., Wang, W., & Dong, Y. (2023). Clinical Efficacy of Cognitive Behavioral Therapy Combined with Pinaverium Bromide Tablets on Irritable Bowel Syndrome.
Pakistan Journal of Medical Sciences,
39(4), 1013-1017.
https://doi.org/10.12669/pjms.39.4.6994
Lorefice, L., D’Alterio, M. N., Firinu, D., Fenu, G., & Cocco, E. (2023). Impact of Menopause in Patients with Multiple Sclerosis: Current Perspectives.
International Journal of Women's Health,
1(2), 103-109.
https://doi.org/10.2147/ijwh.s334719
Miao, X., Wu, L., Wang, K., Wang, Y., & Zhang, L. (2025). Risk factors for coronary atherosclerotic heart disease in postmenopausal women: a meta-analysis.
Frontiers in Cardiovascular Medicine,
1(1), 1-10.
https://doi.org/10.3389/fcvm.2024.1434149
Mnatsakanyan, M. G., Pogromov, A. P., Zuev, V. M., Diukova, G. M., & Tashchayn, O. V. (2022). Irritable bowel syndrome in women of reproductive and menopausal age.
Sechenov Medical Journal, (3), 70-78.
https://www.sechenovmedj.com/jour/article/view/661/364
Nageswari, C., Meena, N., Gupta, S., & Thillaieaswaran, B. (2025). Effect of Pilates Exercises on Pain, Endurance, Quality‐of‐Life, and Disability in Postmenopausal Women With Low Back Pain.
Musculoskeletal Care,
23(1), 1-15.
https://doi.org/10.1002/msc.70071
Nwadi, C. L., Edeh, N. I., Ugwunwoti, E. P., Nwokike, F. O., Nneji, O. S., Anamezie, R. C., ... & Okoli, S. N. (2025). Impact of cognitive-behavioral therapy and mindfulness-based stress reduction in mitigating test anxiety and enhancing academic achievement among vocational education students at Nigerian universities.
BMC Medical Education,
25(1), 578-598.
https://doi.org/10.1186/s12909-025-07130-w
Oliveira, R., Martins, V., de Sousa, H. T., & Roseira, J. (2024). Food-related quality of life and its predictors in inflammatory bowel disease.
Digestive Diseases and Sciences,
69(5), 1793-1802.
https://doi.org/10.1007/s10620-024-08333-9
Patrick, D. L., Drossman, D. A., Frederick, I. O., Dicesare, J., & Puder, K. L. (1998). Quality of life in persons with irritable bowel syndrome (development and validation of a new measure).
Digestive Diseases and Sciences,
43(1), 400-411.
https://doi.org/10.1023/a:1018831127942
Pemberton, L., Kita, L., & Andrews, K. (2020). Practitioners’ experiences of using Gut Directed Hypnosis for irritable bowel syndrome: Perceived impact upon client wellbeing: A qualitative study.
Complementary Therapies in Medicine,
55(1), 1-10.
https://doi.org/10.1016/j.ctim.2020.102605
Peters, S. L., Gibson, P. R., & Halmos, E. P. (2023). Smartphone app‐delivered gut‐directed hypnotherapy improves symptoms of self‐reported irritable bowel syndrome: A retrospective evaluation.
Neurogastroenterology & Motility,
35(4), 1-10.
https://doi.org/10.1111/nmo.14533
Peters, S. L., Muir, J. G., & Gibson, P. R. (2015). gut‐directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease.
Alimentary pharmacology & therapeutics,
41(11), 1104-1115.
https://doi.org/10.1111/apt.13202
Radziwon, C. D., Quigley, B. M., Vargovich, A. M., Krasner, S. S., Gudleski, G. D., Mason, S. R., ... & Lackner, J. M. (2022). Do I really have to do my homework? The role of homework compliance in cognitive behavioral therapy for irritable bowel syndrome.
Behaviour Research and Therapy,
152(1), 1-10.
https://doi.org/10.1016/j.brat.2022.104063
Roger, A. H., Gudleski, G. D., Quigley, B. M., Zvolensky, M. J., & Lackner, J. M. (2023). Pain Catastrophizing and Clinical Outcomes Among Patients Receiving a Novel Cognitive-Behavioral Therapy for Irritable Bowel Syndrome: An Experimental Therapeutics Approach.
Behavior Therapy,
54(4), 623-636.
https://doi.org/10.1016/j.beth.2023.01.004
Rouhi, M., Manzari Tavakoli. A., & Tajrobehkar, M. (2023). The Effectiveness of Cognitive Behavioral Therapy on Coherent Self- Knowledge, Emotion Regulation, and Quality of Life of Hemodialysis Patients: A Quasi-Experimental Study.
Journal of Rafsanjan University of Medical Sciences, 21(10), 1055-1077.
http://dx.doi.org/10.52547/jrums.21.10.1055 [In Persian]
Roukas, C., Miller, L., Cléirigh Büttner, F., Hamborg, T., Stagg, I., Hart, A., ... & Mihaylova, B. (2025). Impact of pain, fatigue and bowel incontinence on the quality of life of people living with inflammatory bowel disease: A UK cross‐sectional survey.
United European Gastroenterology Journal,
13(3), 364-375.
https://doi.org/10.1002/ueg2.12668
Sarnoff, R. P., Hreinsson, J. P., Kim, J., Sperber, A. D., Palsson, O. S., Bangdiwala, S. I., & Chang, L. (2025). Sex Differences, Menses‐Related Symptoms and Menopause in Disorders of Gut–Brain Interaction.
Neurogastroenterology & Motility,
1(2), 1-10.
https://doi.org/10.1111/nmo.14977
Veisi, S., & Kashefi, F. (2025). effectiveness of intensive short-term dynamic psychotherapy on executive functioning, theory of mind and mentalization in people with borderline personality disorder,
New Advances in Behavioral Sciences, 10 (58), 340-353.
https://ijndibs.com/article-1-1164-fa.html [In Persian]
Wang, C., Sheng, Y., Yu, L., Tian, F., Xue, Y., & Zhai, Q. (2023). Effects of cognitive behavioral therapy on mental health and quality of life in inflammatory bowel disease patients: a meta-analysis of randomized controlled trials.
Behavioural Brain Research,
1(1), 1-10.
https://doi.org/10.1016/j.bbr.2023.114653
Whorwell, P. J., Prior, A., & Faragher, E. B. (1984). Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome.
The Lancet,
324(8414), 1232-1234.
https://doi.org/10.1016/s0140-6736(84)92793-4
Yao, Y., Cai, X., Chen, Y., Zhang, M., & Zheng, C. (2025). Estrogen deficiency‐mediated osteoimmunity in postmenopausal osteoporosis.
Medicinal Research Reviews,
45(2), 561-575.
https://doi.org/10.1002/med.22081
Yin, Y., Lu, X., Li, Z., Liu, S., Shao, L., Cao, L., ... & Zhu, W. M. (2022). Risk factors for worsening of bone loss in patients newly diagnosed with inflammatory bowel disease.
Gastroenterology Research and Practice,
1(2), 1-10.
https://doi.org/10.1155/2022/1498293
Zhu, W., Zhang, Y., Wang, L. D. L., Li, J., & Hou, S. (2025). Factors influencing food‐related quality of life in patients with inflammatory bowel disease: A systematic review.
Journal of Evaluation in Clinical Practice,
31(2), 1-10.
https://doi.org/10.1111/jep.14133